Women's Fem Dophilus By Jarrow Formulas Overview & Drug Interactions

Check For Interactions With Women's Fem Dophilus

Supplement: Women's Fem Dophilus by Jarrow Formulas

Women's Fem Dophilus Label Images

supplement image

View and download

full size label image

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Women's Fem Dophilus by Jarrow Formulas

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with Women's Fem Dophilus. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.

Still looking for more information about Women's Fem Dophilus interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container 30
UPC/BARCODE 790011030416

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Proprietary Probiotic Blend
134 mg
Proprietary Blend --
Lactobacillus rhamnosus, GR-1
0 NP
Lactobacillus rhamnosus --
Lactobacillus reuteri, RC-14
0 NP
Lactobacillus reuteri --

Other Ingredients:
Maltodextrin
Hydroxypropylmethylcellulose
Titanium Dioxide
Cellulose
Magnesium Stearate


Label Statments:


Formula
- GR-1/RC-14 and vaginal flora (also called microbiota)
- Fem-Dophilus contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.
General Statements
- In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement. Martinez, et al. Can J Microbiol 2009;55:133-138 Box contains smaller, Activ-Vial moisture-controlled desiccant bottle for better stability of probiotic bacteria. 25+ years of GR-1/RC-14 Research/Clinical studies 1988 First research on GR-1/RC-14 strains begin 27 Clinical studies published between 2001 and 2014 2006 Fem-Dophilus introduced (2006)
- 25+ years of research/clinical studies
- Veggie Cap
Suggested/Recommended/Usage/Directions
- Usage: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
Precautions
- Note: Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition; if adverse reactions occur, discontinue use.
- Note: Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition; if adverse reactions occur, discontinue use.
- Keep out of the reach of children.
Formulation
- Updates based on official taxonomy reclassification.
- Vaginal/urinary tract health
- Free of major allergens
- Suitable for vegetarians/vegans
- No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.
- Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date.
- Gluten free
- V Vegan
- Made in Denmark by Chr. Hansen A/S
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Brand IP Statement(s)
- Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others. RC-14 and GR-1 are registered trademarks of Chr. Hansen A/S. Strains Matter Jarrow Formulas probiotics contain clinically documented strains
- Copyright 2021 Jarrow Formulas
Storage
- No refrigeration necessary
- Fem-Dophilus does not require refrigeration and best to store in cool, dry place. Avoid storage at temperature above 77 degrees F (25 degrees C). Refrigeration, however extends shelf life.
FDA Statement of Identity
- Oral Probiotic Supplement
Seals/Symbols
- Ipro

Brand Information

See all products by this brand

Distributed exclusively by
Name Jarrow Formulas
City Los Angeles
State CA
ZipCode 90035-4317
Phone Number 1-866-459-4154

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.